The in vivo sparing of methionine by cysteine in sulfur amino acid requirements in animal models and adult humans.
Sulfur amino acid metabolism has been receiving increased attention because of the link to chronic diseases such as cardiovascular disease, Alzheimer's disease, and diabetes. In addition, the role of cysteine and optimal intakes for physiological substrates such as glutathione are currently of considerable interest in human health. Although the dietary indispensability of methionine is not in question, the ability of cysteine to substitute for a portion of its requirement has been the topic of much debate. Methionine is often the most limiting amino acid in the diets of the developing world's population because of its low concentration in cereal grains. Therefore, the ability of cysteine to substitute for methionine requirement is not just biologically interesting; it is also of considerable economic and social importance. The primary goal of this review is to discuss the available evidence on the effect of cysteine substitution for methionine to meet the total sulfur amino acid requirement in adult humans, including an assessment of the methodological features of experiments with conflicting results. Assessment of the requirement experiments for amino acids with complex metabolism such as methionine and cysteine must begin with a careful definition of requirements and what substitution means. As a result of these definitions, a set of criteria for the intakes of methionine that will allow demonstration of the substitution effect have been developed. Some recent publications are assessed using these definitions and criteria, and a possible reason for the conflicting results in the literature is proposed. An approach to estimating tolerable upper intakes is also proposed. Research on in vivo sulfur amino acid metabolism in humans is tremendously difficult, and therefore, we do not wish to be overly critical of the high-quality work of the ambitious and highly intelligent men and women who have conducted various studies. Our goal is to objectively review the data for the reader in a logical and comprehensive manner and propose methods that may avoid difficulties in future studies.
Ball
Ronald O
RO
Department of Nutritional Science and Pediatrics, the University of Toronto, Toronto, Canada. ron.ball@ualberta.ca
Courtney-Martin
Glenda
G
Pencharz
Paul B
PB
D000603:Amino Acids, Sulfur / Q000008:administration & dosage* / Q000378:metabolism; D000818:Animals; D001682:Biological Availability; D003545:Cysteine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D008715:Methionine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D023421:Models, Animal; D008970:Molecular Weight; D009584:Nitrogen / Q000378:metabolism; D009751:Nutritional Requirements; D010084:Oxidation-Reduction
D000603:Amino Acids, Sulfur; D008715:Methionine; D003545:Cysteine; D009584:Nitrogen